4
Changes in Ownership
ACADIA PHARMACEUTICALS INC Filed Acc 0001568249-26-000002
EVP, CHIEF LEGAL OFFICER, SEC sold 6,950 shares at $23.38 ($162,491)
- EVP, CHIEF LEGAL OFFICER, SEC acquired 12,944 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Rhodes Jennifer J EVP, CHIEF LEGAL OFFICER, SEC | 2026-02-06 | Option exercise | +12,944 | 14,559 | D | ||
| Rhodes Jennifer J EVP, CHIEF LEGAL OFFICER, SEC | 2026-02-09 | Sale | −6,950 | $23.38 | $162,491 | 7,609 | D |
| Derivatives | |||||||
| Rhodes Jennifer J EVP, CHIEF LEGAL OFFICER, SEC | 2026-02-06 | Option exercise · Restricted Stock Units | −12,944 | 12,945 | D | ||
| Open-market sales · 6,950 sh · avg $23.38 · $162,491 | |||||||
Loading xslF345X05/form4-02102026_060201.xml…